Related Experiment Videos
Antimicrobial therapy for intraabdominal infection
1Department of Surgery, Toronto Hospital, Ontario, Canada.
American Journal of Surgery
|December 1, 1996
Summary
Effective antimicrobial therapy is crucial for intraabdominal infections. Guidelines recommend empiric treatment targeting common bacteria like Escherichia coli and Bacteroides fragilis, considering efficacy, safety, and cost.
Area of Science:
- Infectious Diseases
- Pharmacology
- Clinical Medicine
Background:
- Intraabdominal infections (IAIs) require timely and appropriate antimicrobial therapy for optimal management.
- Advances in understanding microbial pathogens, new antimicrobial agents, and clinical trials have improved IAI treatment over three decades.
Purpose of the Study:
- To provide an overview of antimicrobial therapy approaches for intraabdominal infections.
- To guide clinicians in selecting appropriate antimicrobial regimens based on current evidence.
Main Methods:
- A literature review was conducted, synthesizing data from experimental and clinical studies.
- Information was gathered on the microbiology and treatment of intraabdominal infections.
Main Results:
- Evidence supports empiric antimicrobial therapy against Escherichia coli, Enterobacteriaceae, and Bacteroides fragilis.
- Selection of antimicrobial regimens should consider spectrum, efficacy from animal and clinical studies, safety, pharmacokinetics, and cost.
Conclusions:
- Antimicrobial therapy is a critical component in managing intraabdominal infections.
- Treatment decisions should be guided by results from well-designed clinical trials evaluating various therapeutic aspects.